Ali Akin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Akin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Talat Soner Yilmaz
Internal Medicine, Şanlıurfa Mehmet Akif İnan Training and Research Hospital, Sanlıurfa, Turkey
2 shared publications - Yılmaz Safi̇
EmergencyMedicine, Şanlıurfa Mehmet Akif, Inan Training and Research Hospital, Şanlıurfa, Turkey
2 shared publications - Adnan Turkel
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi, Internal Medicine Specialist Clinic, Haliliye Şanlıurfa, Turkey
1 shared publication Akgul Arici
1 shared publication- Ayse Kevser Demir
Department of Internal Medicine, Faculty of Medicine, Samsun University, 55090 Samsun, Türkiye
1 shared publication - Aziz Batu
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi, Internal Medicine Specialist Clinic, Haliliye Şanlıurfa, Turkey
1 shared publication
Latest Publications
- 1 October 2026
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 7 (2) , 1-5
Evaluation of the Effect of Vaccination Status on Lung Involvement and Hospitalization in COVID-19 Patients
Background: The spectrum of COVID-19 in adults ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome (ARDS) and multiorgan dysfunction. In our study, it was aimed to investigate the effects of COVID- 19 vaccine on lung involvement and hospitalization. Materials and Methods: Cases over the age of 18, who had a history of contact with cases infected with COVID-19 or had clinical findings suggestive of COVID-19, who applied to the emergency department and who were diagnosed with COVID-19 by reverse-transcriptase-polymerase chain reaction (RT-PCR) were included in the study. Age, gender, comorbid diseases, hospitalization status, thorax tomography findings, and vaccination status in the last 3 months of the patients included in the study were obtained by examining the hospital information system and patient files. Results: Our study included 496 patients. One hundred eighty-three of the cases were vaccinated and 42.6% (n = 78) of the vaccinated patients were male. Of the 313 unvaccinated patients, 36% (n = 113) were male. Comorbid disease was observed in 55.2% (n = 101) of the vaccinated patients and 38.7% (n = 121) of the unvaccinated patients. Of the 313 unvaccinated patients, 72.2% (n = 226) were discharged from the emergency department, 19.8% (n = 62) were admitted to the service, and 8% (n = 25) were admitted to the intensive care unit. Of the 183 vaccinated patients, 78.1% (n = 143) were discharged from the emergency department, 16.4% (n = 30) were admitted to the service, and 5.5% (n = 10) were admitted to the intensive care unit. In the vaccinated patient group, both the service admission rate and the intensive care hospitalization rate were found to be significantly lower than the non-vaccinated patient group (p < 0.05). Thoracic tomography findings of 32.9% (n = 103) of 313 unvaccinated patients were reported as CORADS 1-2-3, and thoracic tomography of the remaining 210 patients was reported as CORADS 4-5. The number of patients whose thorax tomography report was CORADS 4-5 was found to be significantly higher in the unvaccinated group than in the vaccinated group (p < 0.05). Conclusion: In our study, it was found that vaccination significantly reduced hospitalization in COVID-19 patients. Although the mean age was higher in the vaccinated patient group, both the service admission rate and the intensive care admission rate were found to be lower.
- 1 October 2026
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 7 (2) , 1-5
Evaluation of the Effect of Vaccination Status on Lung Involvement and Hospitalization in COVID-19 Patients
Background: The spectrum of COVID-19 in adults ranges from asymptomatic infection to mild respiratory tract symptoms to severe pneumonia with acute respiratory distress syndrome (ARDS) and multiorgan dysfunction. In our study, it was aimed to investigate the effects of COVID- 19 vaccine on lung involvement and hospitalization. Materials and Methods: Cases over the age of 18, who had a history of contact with cases infected with COVID-19 or had clinical findings suggestive of COVID-19, who applied to the emergency department and who were diagnosed with COVID-19 by reverse-transcriptase-polymerase chain reaction (RT-PCR) were included in the study. Age, gender, comorbid diseases, hospitalization status, thorax tomography findings, and vaccination status in the last 3 months of the patients included in the study were obtained by examining the hospital information system and patient files. Results: Our study included 496 patients. One hundred eighty-three of the cases were vaccinated and 42.6% (n = 78) of the vaccinated patients were male. Of the 313 unvaccinated patients, 36% (n = 113) were male. Comorbid disease was observed in 55.2% (n = 101) of the vaccinated patients and 38.7% (n = 121) of the unvaccinated patients. Of the 313 unvaccinated patients, 72.2% (n = 226) were discharged from the emergency department, 19.8% (n = 62) were admitted to the service, and 8% (n = 25) were admitted to the intensive care unit. Of the 183 vaccinated patients, 78.1% (n = 143) were discharged from the emergency department, 16.4% (n = 30) were admitted to the service, and 5.5% (n = 10) were admitted to the intensive care unit. In the vaccinated patient group, both the service admission rate and the intensive care hospitalization rate were found to be significantly lower than the non-vaccinated patient group (p < 0.05). Thoracic tomography findings of 32.9% (n = 103) of 313 unvaccinated patients were reported as CORADS 1-2-3, and thoracic tomography of the remaining 210 patients was reported as CORADS 4-5. The number of patients whose thorax tomography report was CORADS 4-5 was found to be significantly higher in the unvaccinated group than in the vaccinated group (p < 0.05). Conclusion: In our study, it was found that vaccination significantly reduced hospitalization in COVID-19 patients. Although the mean age was higher in the vaccinated patient group, both the service admission rate and the intensive care admission rate were found to be lower.
- 2 March 2026
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 81 (3) , 258-268
Assessing the ability of SARC-F to reflect elastography-based muscle quality in older adults
- 2 March 2026
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 81 (3) , 258-268
Assessing the ability of SARC-F to reflect elastography-based muscle quality in older adults
- Open Access
- 12 September 2025
- Published by Academician Publishing
- p. 11-20
Mide Adenokarsinomu ile Birlikte Görülen Mezenterik Pannükülit Olgusu
Yirmi iki yaşında erkek hasta, yoğun fiziksel egzersiz sonrası gelişen halsizlik, karın ağrısı ve iştahsızlık şikayetleri ile başvurdu. İlk başvuruda semptomatik tedavi düzenlenmesine rağmen yakınmaları gerilemeyen hastanın ikinci başvurusunda yapılan tetkiklerde belirgin kreatin kinaz (CK) yüksekliği (36 874 U/L) saptandı ve rabdomiyoliz ön tanısı ile İç Hastalıkları servisine yatırıldı. Erken dönemde başlanan yoğun intravenöz sıvı tedavisi ile CK düzeyleri ve diğer kas enzimlerinde kademeli düşüş izlendi ve hastalık süresince renal komplikasyon gelişmedi. Ayırıcı tanı amacıyla yapılan otoimmün panel, tiroid fonksiyon testleri, viral serolojiler ve elektrolit düzeylerinde patoloji saptanmadı. Klinik bulgular, laboratuvar değerleri ve görüntüleme sonuçları egzersize bağlı rabdomiyoliz tanısını destekledi. Bu olgu, genç erişkinlerde yoğun egzersiz sonrası gelişebilen rabdomiyolizin erken tanı ve etkin sıvı replasmanı ile komplikasyonsuz seyredebileceğini vurgulamaktadır.
- 12 September 2025
- Published by Academician Publishing
- p. 11-20
Open AccessMide Adenokarsinomu ile Birlikte Görülen Mezenterik Pannükülit Olgusu
Yirmi iki yaşında erkek hasta, yoğun fiziksel egzersiz sonrası gelişen halsizlik, karın ağrısı ve iştahsızlık şikayetleri ile başvurdu. İlk başvuruda semptomatik tedavi düzenlenmesine rağmen yakınmaları gerilemeyen hastanın ikinci başvurusunda yapılan tetkiklerde belirgin kreatin kinaz (CK) yüksekliği (36 874 U/L) saptandı ve rabdomiyoliz ön tanısı ile İç Hastalıkları servisine yatırıldı. Erken dönemde başlanan yoğun intravenöz sıvı tedavisi ile CK düzeyleri ve diğer kas enzimlerinde kademeli düşüş izlendi ve hastalık süresince renal komplikasyon gelişmedi. Ayırıcı tanı amacıyla yapılan otoimmün panel, tiroid fonksiyon testleri, viral serolojiler ve elektrolit düzeylerinde patoloji saptanmadı. Klinik bulgular, laboratuvar değerleri ve görüntüleme sonuçları egzersize bağlı rabdomiyoliz tanısını destekledi. Bu olgu, genç erişkinlerde yoğun egzersiz sonrası gelişebilen rabdomiyolizin erken tanı ve etkin sıvı replasmanı ile komplikasyonsuz seyredebileceğini vurgulamaktadır.
- Open Access
- 14 March 2025
- Published by Bentham Science Publishers Ltd. in New Emirates Medical Journal
- Vol. 05 (1) , 1-6
Evaluation of Factors Associated with Mortality in Patients with Crush Syndrome Acquired from the February 6 Kahramanmaras Earthquake
Background: Crush syndrome is the second most common cause of death in earthquakes, following direct trauma. Crush syndrome develops when toxic substances released after tissue injury or crushing reach the bloodstream. The aim of this study was to investigate factors associated with morbidity and mortality in patients rescued from the rubble after the February 6 earthquake and admitted to our hospital who had crush syndrome by retrospectively analyzing their data. Methods: Hemodialysis, fasciotomy, and other parameters during hospitalization and time to transfer to a ward or death of 36 adult patients with crush syndrome who were rescued from the rubble and hospitalized after the February 6 earthquake were retrospectively analyzed. Results: Thirty-six patients were included in the study. There was no significant correlation between the mortality of patients according to their time of rescue or need for fasciotomy, dialysis, or inotropes (p=0.767, p=0.294, p=0.625, p=0.865, respectively). There was a high inverse correlation between the time of rescue and time to death. There was a weak inverse correlation between the time of rescue and hospitalization duration (r=-0.767 and r=-0.341, respectively). There was a significant correlation between the need for inotropes and mortality (p<0.001). No one who didn't need dialysis passed away. Dialysis was necessary for all six of the deceased individuals. We can conclude that one significant factor in predicting death in CS patients is the requirement for dialysis. Conclusion: Crush syndrome, which develops in patients rescued from the rubble alive, is a life-threatening condition. It is an important syndrome and an important cause of mortality for earthquake victims. Further large-scale studies are needed to elucidate the association of time of rescue, the need for fasciotomy and hemodialysis, and other factors with mortality.
- 14 March 2025
- Published by Bentham Science Publishers Ltd. in New Emirates Medical Journal
- Vol. 05 (1) , 1-6
Open AccessEvaluation of Factors Associated with Mortality in Patients with Crush Syndrome Acquired from the February 6 Kahramanmaras Earthquake
Background: Crush syndrome is the second most common cause of death in earthquakes, following direct trauma. Crush syndrome develops when toxic substances released after tissue injury or crushing reach the bloodstream. The aim of this study was to investigate factors associated with morbidity and mortality in patients rescued from the rubble after the February 6 earthquake and admitted to our hospital who had crush syndrome by retrospectively analyzing their data. Methods: Hemodialysis, fasciotomy, and other parameters during hospitalization and time to transfer to a ward or death of 36 adult patients with crush syndrome who were rescued from the rubble and hospitalized after the February 6 earthquake were retrospectively analyzed. Results: Thirty-six patients were included in the study. There was no significant correlation between the mortality of patients according to their time of rescue or need for fasciotomy, dialysis, or inotropes (p=0.767, p=0.294, p=0.625, p=0.865, respectively). There was a high inverse correlation between the time of rescue and time to death. There was a weak inverse correlation between the time of rescue and hospitalization duration (r=-0.767 and r=-0.341, respectively). There was a significant correlation between the need for inotropes and mortality (p<0.001). No one who didn't need dialysis passed away. Dialysis was necessary for all six of the deceased individuals. We can conclude that one significant factor in predicting death in CS patients is the requirement for dialysis. Conclusion: Crush syndrome, which develops in patients rescued from the rubble alive, is a life-threatening condition. It is an important syndrome and an important cause of mortality for earthquake victims. Further large-scale studies are needed to elucidate the association of time of rescue, the need for fasciotomy and hemodialysis, and other factors with mortality.
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 6 (1) , 1-5
Biochemical and Familial Factors Influencing COVID-19 Disease Progression
Introduction: COVID-19 is a global pandemic that has caused significant mortality. The disease severity varies among individuals, and the factors influencing its course remain unclear. This study aimed to investigate the influence of biochemical parameters and familial data on COVID-19 outcomes. Methods: A retrospective analysis of 122 COVID-19 patients was conducted. Patients were categorized into two groups: outpatients with mild symptoms and those admitted to the intensive care unit (ICU) and intubated. Demographic data, biochemical levels of vitamin D, vitamin B12, and magnesium, and COVID-19 outcomes of first-, second-, and third-degree relatives were collected. Results: The ICU group had a higher proportion of males (75%) and older patients (average age: 63.18±12.89 years) than the outpatient group (40% males and an average age of 45.13±13.77 years). Both groups had similar BMI, vitamin D, and vitamin B12 levels. However, magnesium levels were significantly higher in the ICU group (mean 2.25±0.3 mg/dL) than in the outpatient group (mean: 1.98±0.2 mg/dL). A significant familial relationship was identified between COVID-19 outcomes and disease course. Among the ICU patients, 25% had first-degree relatives who died from COVID- 19, compared to only 10% of the outpatient patients. Similarly, second- and third-degree relatives of ICU patients had a higher mortality rate from COVID-19 than relatives of outpatient patients. Conclusion:: Age, gender, and magnesium levels may influence COVID-19 disease severity. Familial ties (genetic relatedness) may also play a role, suggesting potential genetic predisposition. Further research is needed to validate these findings and elucidate the underlying mechanisms
- 1 February 2025
- Published by Bentham Science Publishers Ltd. in Coronaviruses
- Vol. 6 (1) , 1-5
Biochemical and Familial Factors Influencing COVID-19 Disease Progression
Introduction: COVID-19 is a global pandemic that has caused significant mortality. The disease severity varies among individuals, and the factors influencing its course remain unclear. This study aimed to investigate the influence of biochemical parameters and familial data on COVID-19 outcomes. Methods: A retrospective analysis of 122 COVID-19 patients was conducted. Patients were categorized into two groups: outpatients with mild symptoms and those admitted to the intensive care unit (ICU) and intubated. Demographic data, biochemical levels of vitamin D, vitamin B12, and magnesium, and COVID-19 outcomes of first-, second-, and third-degree relatives were collected. Results: The ICU group had a higher proportion of males (75%) and older patients (average age: 63.18±12.89 years) than the outpatient group (40% males and an average age of 45.13±13.77 years). Both groups had similar BMI, vitamin D, and vitamin B12 levels. However, magnesium levels were significantly higher in the ICU group (mean 2.25±0.3 mg/dL) than in the outpatient group (mean: 1.98±0.2 mg/dL). A significant familial relationship was identified between COVID-19 outcomes and disease course. Among the ICU patients, 25% had first-degree relatives who died from COVID- 19, compared to only 10% of the outpatient patients. Similarly, second- and third-degree relatives of ICU patients had a higher mortality rate from COVID-19 than relatives of outpatient patients. Conclusion:: Age, gender, and magnesium levels may influence COVID-19 disease severity. Familial ties (genetic relatedness) may also play a role, suggesting potential genetic predisposition. Further research is needed to validate these findings and elucidate the underlying mechanisms
- 20 October 2024
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Diyabetli Hastalarda Diyabetik Periferal Nöropati ile İlişkili Faktörlerin Değerlendirilmesi
Giriş: Diyabetik periferal nöropati, diyabetin uzun sürede görülen ve göz ardı edilen önemli bir komplikasyonudur. Diyabetik polinöropatinin (DPN) varlığı, tekrarlayan alt ekstremite enfeksiyonları, ülserasyonlar ve takip eden ampütasyonlar başta olmak üzere ciddi morbiditelere yol açar ve erken tanınması önem taşımaktadır. Çalışmamızda DPN ile ilişkili faktörlerin irdelenmesi ve nöropatide hızlı tanı testiyle erken ve hızlı teşhisin önemi vurgulanmaya çalışılmıştır. Materyal Metod: Diyabetes Mellitus (DM) tanılı hastalara Diyabetik Nöropatik Ağrı Anketi (Douler Neuropathique 4 Questions DN-4) yapıldı. Ayrıca dokunma hipoestezisi iğne hipoestezizi ve extremitede dokunma ile ağrı olup olmadığı muayene edildi. Hastaların demografik özellikleri sorgulanıp kayıt edildi. Rutin labaratuar sonuçlarından elde edilen veriler kayıt altına alındı. Bulgular: Çalışmaya 60 kadın (%57.7) 44 (%42.3) erkek hasta alındı. Çalışmaya alınan hastaların 56’sında (%53.8) Diyabetik Nöropati saptandı. DN-4 skoru ile HbA1c ve Diyabet yıl arasında yüksek korelasyon saptandı (sırasıyla r=0.791, p< 0.001, r =0.692, p< 0.001 ). DN-4 skoru LDL kolesterol trigliserid düzeyi arasında zayıf korelasyon saptandı (sırasıyla r= 0.124, p=0.364, r=0.183, p=0.176). DN-4 Skoruna göre Diyabetik Nöropati olan hastalar sınıflandırıldığında cinsiyete bağlı her iki grup arasında farklılık saptanmadı (p=0.383). Çalışmamızda 62 yaş DPN için kesim noktası değeri olarak saptandı (p<0.001). Buna göre hasta yaşının 62 yıl üstü olması DPN için kesim noktası değeridir. Bu ileri yaş ile DPN riskininin arttığını göstermektedir. Ayrıca HbA1c 7,6 üzeri olması DPN tanısı için ve 6 yıl ve üzeri diyabet geçmişi olması DPN gelişmesi için anlamlı olarak saptandı (p<0.001). Sonuç: Çalışmamıza göre yüksek HbA1c, ileri yaş ve diyabet süresinin artmasıyla DPN riski artış göstermektedir. Çalışmamız tarama testlerinin poliklinik şartlarında yapılabilirliğini göstermesi ve farkındalık oluşturması açısından önemlidir.
- 20 October 2024
- Published by Sakarya Tip Dergisi in Sakarya Medical Journal
Diyabetli Hastalarda Diyabetik Periferal Nöropati ile İlişkili Faktörlerin Değerlendirilmesi
Giriş: Diyabetik periferal nöropati, diyabetin uzun sürede görülen ve göz ardı edilen önemli bir komplikasyonudur. Diyabetik polinöropatinin (DPN) varlığı, tekrarlayan alt ekstremite enfeksiyonları, ülserasyonlar ve takip eden ampütasyonlar başta olmak üzere ciddi morbiditelere yol açar ve erken tanınması önem taşımaktadır. Çalışmamızda DPN ile ilişkili faktörlerin irdelenmesi ve nöropatide hızlı tanı testiyle erken ve hızlı teşhisin önemi vurgulanmaya çalışılmıştır. Materyal Metod: Diyabetes Mellitus (DM) tanılı hastalara Diyabetik Nöropatik Ağrı Anketi (Douler Neuropathique 4 Questions DN-4) yapıldı. Ayrıca dokunma hipoestezisi iğne hipoestezizi ve extremitede dokunma ile ağrı olup olmadığı muayene edildi. Hastaların demografik özellikleri sorgulanıp kayıt edildi. Rutin labaratuar sonuçlarından elde edilen veriler kayıt altına alındı. Bulgular: Çalışmaya 60 kadın (%57.7) 44 (%42.3) erkek hasta alındı. Çalışmaya alınan hastaların 56’sında (%53.8) Diyabetik Nöropati saptandı. DN-4 skoru ile HbA1c ve Diyabet yıl arasında yüksek korelasyon saptandı (sırasıyla r=0.791, p< 0.001, r =0.692, p< 0.001 ). DN-4 skoru LDL kolesterol trigliserid düzeyi arasında zayıf korelasyon saptandı (sırasıyla r= 0.124, p=0.364, r=0.183, p=0.176). DN-4 Skoruna göre Diyabetik Nöropati olan hastalar sınıflandırıldığında cinsiyete bağlı her iki grup arasında farklılık saptanmadı (p=0.383). Çalışmamızda 62 yaş DPN için kesim noktası değeri olarak saptandı (p<0.001). Buna göre hasta yaşının 62 yıl üstü olması DPN için kesim noktası değeridir. Bu ileri yaş ile DPN riskininin arttığını göstermektedir. Ayrıca HbA1c 7,6 üzeri olması DPN tanısı için ve 6 yıl ve üzeri diyabet geçmişi olması DPN gelişmesi için anlamlı olarak saptandı (p<0.001). Sonuç: Çalışmamıza göre yüksek HbA1c, ileri yaş ve diyabet süresinin artmasıyla DPN riski artış göstermektedir. Çalışmamız tarama testlerinin poliklinik şartlarında yapılabilirliğini göstermesi ve farkındalık oluşturması açısından önemlidir.
- Open Access
- 20 January 2023
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 13 (1) , 73-79
COVID-19’a Bağlı Sitokin Fırtınasında Anakinra ve Tosilizumab Tedavilerinin Karşılaştırılması
Amaç: Koronavirüs-19 hastalığına (COVID-19) bağlı gelişen sitokin fırtınasının (SF) mortalite ve morbiditeyi etkilemede önemli olduğu düşünülmektedir. Çalışmamızda yoğun bakım kliniğinde SF nedenli yatan hastalarda tosilizumab ile anakinranın etkinliklerinin karşılaştırılması amaçlanmıştır. Gereç ve Yöntemler: Çalışmaya Ocak 2021-Aralık 2021 tarihleri arasında SF gelişen 69 hasta alındı. Anakinra veya tosilizumab tedavisi alan hastaların aldıkları tedavi süreleri ve dozları, daha önce aldıkları tedaviler (favipiravir ve pulse steroid) kayıt altına alındı. Hastaların biyokimyasal parametreleri retrospektif olarak incelendi. Bulgular: Sitokin fırtınası olan olguların 42’si (% 60,9) anakinra, 27’si (% 39,1) tosilizumab kullanmıştı. Olguların % 39,1’i (n=27) kadın, % 60,9’u (n=42) erkekti. Olguların yaşları 27 ile 89 arasında değişmekte olup, ortalama yaş 56,27±13,87 yıl olarak saptandı. İki grup arasında tedavi öncesi ve 48. saatte bakılan; beyaz küre (Wbc), lenfosit, nötrofil, ferritin, C Reaktif Protein (CRP), prokalsitonin, fibrinojen, D-dimer, kreatinin değerleri benzerdi (p> 0,05). Anakinra tedavisi alan 42 hastanın 21’i (% 50) exitus oldu, 21’i (% 50) servise alındı. Tosilizumab tedavisi alan 27 hastanın 23’ü (% 85,2) exitus oldu, 4’ü (% 14,8) servise alındı. Anakinra ve tosilizumab arasında mortalite açısından anlamlı fark olduğu tespit edildi (p= 0,014). Sonuç: Çalışmamızda COVID-19 nedenli SF gelişen hastalarda anakinra tedavisi, tosilizumaba göre mortalite açısından üstün bulunmuştur.
- 20 January 2023
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 13 (1) , 73-79
Open AccessCOVID-19’a Bağlı Sitokin Fırtınasında Anakinra ve Tosilizumab Tedavilerinin Karşılaştırılması
Amaç: Koronavirüs-19 hastalığına (COVID-19) bağlı gelişen sitokin fırtınasının (SF) mortalite ve morbiditeyi etkilemede önemli olduğu düşünülmektedir. Çalışmamızda yoğun bakım kliniğinde SF nedenli yatan hastalarda tosilizumab ile anakinranın etkinliklerinin karşılaştırılması amaçlanmıştır. Gereç ve Yöntemler: Çalışmaya Ocak 2021-Aralık 2021 tarihleri arasında SF gelişen 69 hasta alındı. Anakinra veya tosilizumab tedavisi alan hastaların aldıkları tedavi süreleri ve dozları, daha önce aldıkları tedaviler (favipiravir ve pulse steroid) kayıt altına alındı. Hastaların biyokimyasal parametreleri retrospektif olarak incelendi. Bulgular: Sitokin fırtınası olan olguların 42’si (% 60,9) anakinra, 27’si (% 39,1) tosilizumab kullanmıştı. Olguların % 39,1’i (n=27) kadın, % 60,9’u (n=42) erkekti. Olguların yaşları 27 ile 89 arasında değişmekte olup, ortalama yaş 56,27±13,87 yıl olarak saptandı. İki grup arasında tedavi öncesi ve 48. saatte bakılan; beyaz küre (Wbc), lenfosit, nötrofil, ferritin, C Reaktif Protein (CRP), prokalsitonin, fibrinojen, D-dimer, kreatinin değerleri benzerdi (p> 0,05). Anakinra tedavisi alan 42 hastanın 21’i (% 50) exitus oldu, 21’i (% 50) servise alındı. Tosilizumab tedavisi alan 27 hastanın 23’ü (% 85,2) exitus oldu, 4’ü (% 14,8) servise alındı. Anakinra ve tosilizumab arasında mortalite açısından anlamlı fark olduğu tespit edildi (p= 0,014). Sonuç: Çalışmamızda COVID-19 nedenli SF gelişen hastalarda anakinra tedavisi, tosilizumaba göre mortalite açısından üstün bulunmuştur.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (12) , e20230716
Serum and urinary angiotensinogen levels as prognostic indicators in acute kidney injury: a prospective study
The delayed increase in serum creatinine levels poses challenges in the timely diagnosis of acute kidney injury. This study aimed to investigate the relationship between serum angiotensinogen and urinary angiotensinogen levels and the prognosis of renal function in patients diagnosed with acute kidney injury.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (12) , e20230716
Open AccessSerum and urinary angiotensinogen levels as prognostic indicators in acute kidney injury: a prospective study
The delayed increase in serum creatinine levels poses challenges in the timely diagnosis of acute kidney injury. This study aimed to investigate the relationship between serum angiotensinogen and urinary angiotensinogen levels and the prognosis of renal function in patients diagnosed with acute kidney injury.
- 1 January 2023
- Published by LookUs Bilisim A.S. in Ankara City Hospital Medical Journal
- Vol. 2 (4) , 231-236
Investigating the Relationship of Vitamin D Deficiency and Certain Biochemical Parameters with Depression
- 1 January 2023
- Published by LookUs Bilisim A.S. in Ankara City Hospital Medical Journal
- Vol. 2 (4) , 231-236
Investigating the Relationship of Vitamin D Deficiency and Certain Biochemical Parameters with Depression
- Open Access
- 29 August 2019
- Published by ClinMed International Library in International Journal of Pathology and Clinical Research
- Vol. 5 (2)
Retroperitoneal Malignant Solitary Fibrous Tumor: A Case Report and Review of the Literature
Solitary fibrous tumor is a rare soft-tissue neoplasm that is capable of metastasis of fibroblastic/myofibroblastic cell origin. Although most of the cases are pleural in origin, extrapleural locations are reported with increasing frequency. Extrapleural cases are mostly seen in retroperitoneal location. Malignant forms are much rarer.
- 29 August 2019
- Published by ClinMed International Library in International Journal of Pathology and Clinical Research
- Vol. 5 (2)
Open AccessRetroperitoneal Malignant Solitary Fibrous Tumor: A Case Report and Review of the Literature
Solitary fibrous tumor is a rare soft-tissue neoplasm that is capable of metastasis of fibroblastic/myofibroblastic cell origin. Although most of the cases are pleural in origin, extrapleural locations are reported with increasing frequency. Extrapleural cases are mostly seen in retroperitoneal location. Malignant forms are much rarer.